Search results
Amgen Inc. (NASDAQ:AMGN) Stock Position Decreased by PSI Advisors LLC
ETF DAILY NEWS· 6 days agoPSI Advisors LLC lessened its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 31.8% in the fourth quarter, according to the company in its most recent filing with the Securities ...
Arthritis Medications: NSAIDs, Steroids, Narcotics, Topical Treatments, and More
WebMD· 3 days agoThere are dozens of medications available with or without a prescription to treat the various forms of arthritis. Nonsteroidal anti-inflammatory drugs or NSAIDs are available both over the counter and by prescription.
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 5 days agoIn October 2023, the FDA approved Cosentyx for treating moderate-to-severe hidradenitis suppurativa...
MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Rating Reaffirmed by HC Wainwright
ETF DAILY NEWS· 3 days agoMoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a research report issued to clients and investors on Tuesday ...
More people exposed to Manhattan Project chemicals deserve compensation, advocates say
Fox News via Yahoo News· 3 days agoMissouri Sen. Josh Hawley is pushing to expand payments to those exposed to Manhattan Project...
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 5 days agoThese product candidates are being developed to treat patients with graft-versus-host disease, psoriatic arthritis, alpha-1-antitrypsin deficiency,...
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed...
Benzinga· 4 days agoThe confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® (golimumab), met its primary endpoint in patients with moderate to severe rheumatoid
Sigma Planning Corp Has $1.85 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 6 days agoSigma Planning Corp decreased its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 65.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and ...
Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening...
Morningstar· 6 days agoAd hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Pyzchiva® approved as one of first ustekinumab biosimilars in EuropeEC approval based on robust development program confirming match to reference medicine in terms of safety
Hussman Strategic Advisors Inc. Reduces Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 6 days agoHussman Strategic Advisors Inc. lessened its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 60.0% in the 4th quarter, Holdings Channel reports. The institutional investor owned ...